Xu‐Feng Zhang
- Oncology top 2%
- Surgery top 2%
- Molecular Biology top 10%
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (33 papers)Pancreatic and Hepatic Oncology Research (30 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers)
- Cited by
- HepatologyOncologyCancer Research
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xu‐Feng Zhang
181 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 1.4k
- Surgery 1.3k
- Molecular Biology 898
- Epidemiology 824
- Pulmonary and Respiratory Medicine 791
Countries citing papers authored by Xu‐Feng Zhang
This map shows the geographic impact of Xu‐Feng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu‐Feng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu‐Feng Zhang more than expected).
Fields of papers citing papers by Xu‐Feng Zhang
This network shows the impact of papers produced by Xu‐Feng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu‐Feng Zhang. The network helps show where Xu‐Feng Zhang may publish in the future.
Co-authorship network of co-authors of Xu‐Feng Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Xu‐Feng Zhang. A scholar is included among the top collaborators of Xu‐Feng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu‐Feng Zhang. Xu‐Feng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 26 | |
| 8 | 28 | |
| 9 | 27 | |
| 10 | 17 | |
| 11 | 12 | |
| 12 | 15 | |
| 13 | 13 | |
| 14 | 30 | |
| 15 | 49 | |
| 16 | 8 | |
| 17 | 2 | |
| 18 | 6 | |
| 19 | 12 | |
| 20 | 13 |
About Xu‐Feng Zhang
Xu‐Feng Zhang is a scholar working on Hepatology, Oncology and Surgery, having authored 192 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Pancreatic and Hepatic Oncology Research (30 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers). The work is most often cited by research in Hepatology (673 citations), Oncology (1.4k citations) and Cancer Research (527 citations). Xu‐Feng Zhang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yi Lv, Xuemin Liu, Francis J. White, Jian Dong, Xiu‐Ti Hu, Timothy M. Pawlik, Junxi Xiang, Muxing Li, Connie R. Faltynek and George A. Poultsides. Their work appears in journals such as Nature Genetics, Journal of Neuroscience and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.